SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form S-3 - Registration statement under Securities Act of 1933:
SEC Accession No. 0001628280-24-022632
Filing Date
2024-05-10
Accepted
2024-05-10 16:19:14
Documents
8

Document Format Files

Seq Description Document Type Size
1 S-3 skye-sx3universalshelf.htm S-3 465111
2 EX-FILING FEES exhibit107-sx3universalshe.htm EX-FILING FEES 41963
3 EX-1.2 exhibit12-sx3universalshelf.htm EX-1.2 272333
4 EX-4.5 exhibit45-sx3universalshelf.htm EX-4.5 521805
5 EX-5.1 exhibit51-sx3universalshelf.htm EX-5.1 25904
6 EX-23.1 exhibit231-sx3universalshe.htm EX-23.1 3281
7 fennemorelogoa.jpg GRAPHIC 21616
8 image_0.jpg GRAPHIC 16399
  Complete submission text file 0001628280-24-022632.txt   1384175
Mailing Address 11250 EL CAMINO REAL, SUITE 100 SAN DIEGO CA 92130
Business Address 11250 EL CAMINO REAL, SUITE 100 SAN DIEGO CA 92130 (858) 410-0266
Skye Bioscience, Inc. (Filer) CIK: 0001516551 (see all company filings)

IRS No.: 450692882 | State of Incorp.: NV | Fiscal Year End: 1231
Type: S-3 | Act: 33 | File No.: 333-279331 | Film No.: 24935194
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)